Loreto Carmona to Antirheumatic Agents
This is a "connection" page, showing publications Loreto Carmona has written about Antirheumatic Agents.
Connection Strength
0.592
-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146.
Score: 0.077
-
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020 07; 79(7):859-866.
Score: 0.072
-
Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study. Reumatol Clin (Engl Ed). 2020 Mar - Apr; 16(2 Pt 1):116-119.
Score: 0.063
-
The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern. Rheumatol Int. 2018 09; 38(9):1735-1740.
Score: 0.063
-
Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review. Rheumatol Int. 2018 Jun; 38(6):975-983.
Score: 0.062
-
Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study. Clin Exp Rheumatol. 2018 May-Jun; 36(3):382-388.
Score: 0.061
-
Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study. Rheumatol Int. 2017 Jul; 37(7):1195-1202.
Score: 0.058
-
Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach? Clin Exp Rheumatol. 2017 Sep-Oct; 35(5):816-822.
Score: 0.058
-
Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study. Clin Exp Rheumatol. 2017 May-Jun; 35(3):423-430.
Score: 0.057
-
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021 07; 80(7):930-942.
Score: 0.019